In our preliminary biodistribution analyses, tumor uptake on 64Cu-DOTA-anti-CTLA-4 mAb was not significantly higher than that on 64Cu-DOTA-Control IgG at 24 h after administration of the probes (data was not shown). Here, CTLA4 is linked to neoplasm.